Rita Nanda

Rita Nanda

UNVERIFIED PROFILE

Are you Rita Nanda?   Register this Author

Register author
Rita Nanda

Rita Nanda

Publications by authors named "Rita Nanda"

Are you Rita Nanda?   Register this Author

49Publications

1656Reads

12Profile Views

Immune Checkpoint Inhibitor Therapy in Breast Cancer.

J Natl Compr Canc Netw 2018 10;16(10):1259-1268

View Article

Download full-text PDF

Source
http://www.jnccn.org/lookup/doi/10.6004/jnccn.2018.7046
Publisher Site
http://dx.doi.org/10.6004/jnccn.2018.7046DOI Listing
October 2018

Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.

Cancer 2018 07 9;124(14):3052-3065. Epub 2018 May 9.

Center for Personalized Therapeutics, The University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31382DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354920PMC
July 2018

Immune Checkpoint Blockade for Breast Cancer.

Cancer Treat Res 2018;173:155-165

Section of Hematology/Oncology, 5841 S. Maryland Ave, MC 2115, Chicago, IL, 60616, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-70197-4_10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061922PMC
June 2018

Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.

J Clin Oncol 2018 03 26;36(9):884-890. Epub 2018 Jan 26.

Tiffany A. Traina and Ayca Gucalp, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Kathy Miller, Indiana University Simon Cancer Center, Indianapolis, IN; Denise A. Yardley, Tennessee Oncology, Nashville; Lee S. Schwartzberg, The West Clinic, Memphis, TN; Janice Eakle, Florida Cancer Specialists, Fort Myers, FL; Joyce O'Shaughnessy, Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology, Dallas, TX; William Gradishar, Northwestern University Feinberg School of Medicine; Rita Nanda, University of Chicago, Chicago; Joyce Steinberg, Astellas Pharma, Northbrook, IL; Peter Schmid, Barts Cancer Institute, Queen Mary University London, London, United Kingdom; Eric Winer, Dana-Farber Cancer Institute, Boston, MA; Catherine Kelly, All Ireland Collaborative Oncology Research Group, Dublin, Ireland; Ahmad Awada, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium; Laura Garcia-Estevez, Centro Integral Oncologico Clara Campal, Hospital Madrid Norte-Sanchinarro; Javier Cortes, Ramon y Cajal University Hospital, Madrid, and, Vall d'Hebron Institute of Oncology and Baselga Oncological Institute, Barcelona, Spain; Maureen E. Trudeau, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; and Hirdesh Uppal, Amy Peterson, and Iulia Cristina Tudor, Medivation, San Francisco, CA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.71.3495
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.71.3495DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858523PMC
March 2018

Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge", Napoli, November 30th 2016.

J Transl Med 2017 10 11;15(1):205. Epub 2017 Oct 11.

Department of Urology and Gynecology, Istituto Nazionale Tumori "Fondazione G. Pascale", Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12967-017-1309-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637331PMC
October 2017

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study.

J Clin Oncol 2017 Mar 21;35(7):751-758. Epub 2016 Nov 21.

Kala Visvanathan, Johns Hopkins University School of Medicine and Bloomberg School of Public Health; MaryJo S. Fackler, Zhe Zhang, Zoila A. Lopez-Bujanda, Stacie C. Jeter, Lori J. Sokoll, Leslie M. Cope, Christopher B. Umbricht, David M. Euhus, Saraswati Sukumar, and Antonio C. Wolff, Johns Hopkins University School of Medicine, Baltimore, MD; Elizabeth Garrett-Mayer, Medical University of South Carolina, Charleston, SC; Andres Forero, University of Alabama at Birmingham, Birmingham, AL; Anna M. Storniolo, Indiana University, Bloomington, IN; Rita Nanda, University of Chicago, Chicago, IL; Nancy U. Lin, Dana-Farber Cancer Institute, Boston, MA; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; and James N. Ingle, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.2080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455421PMC
March 2017

Retrospective chart evaluation of hypercalcemia management in oncology patients at the University of Chicago Medical Center.

J Oncol Pharm Pract 2017 Jan 1:1078155217733808. Epub 2017 Jan 1.

21727 University of Chicago Medicine , Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155217733808DOI Listing
January 2017

Concepts and targets in triple-negative breast cancer: recent results and clinical implications.

Ther Adv Med Oncol 2016 Sep 10;8(5):351-9. Epub 2016 Jul 10.

University of Chicago Medical Center, 5841 S. Maryland Ave., MC 2115, Chicago, IL 60637-1470, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834016657071DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981296PMC
September 2016

Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study.

J Clin Oncol 2016 07 2;34(21):2460-7. Epub 2016 May 2.

Rita Nanda, University of Chicago, Chicago, IL; Laura Q.M. Chow, University of Washington, Seattle, WA; E. Claire Dees, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Raanan Berger, Sheba Medical Center, Tel Hashomer; Ravit Geva, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Lajos Pusztai, Yale University School of Medicine, New Haven, CT; Kumudu Pathiraja, Gursel Aktan, Jonathan D. Cheng, and Vassiliki Karantza, Merck & Co., Kenilworth, NJ; and Laurence Buisseret, Université Libre de Bruxelles, Bruxelles, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.8931DOI Listing
July 2016

Adaptive Randomization of Neratinib in Early Breast Cancer.

N Engl J Med 2016 Jul;375(1):11-22

From University of California, San Francisco (J.W.P., C.Y., L.J.V., N.M.H., M.B.B., A.J.C., M.M., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California, San Diego, San Diego (A.M.W., R.S., T.H.), and University of Southern California, Los Angeles (D.T.) - all in California; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.); University of Minnesota, Minneapolis (D.Y., T.C.H.), and Mayo Clinic, Rochester (J.C.B.) - both in Minnesota; M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), University of Texas Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas; Gemini Group, Ann Arbor, MI (J.P.); University of Pennsylvania, Philadelphia (A.D.); Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.); Swedish Medical Center, Seattle (H.G.K.); University of Chicago (R.N.) and Loyola University (K.S.A.) - both in Chicago; Inova Fairfax Hospital, Falls Church, VA (K.K.E.); University of Denver, Denver (A.D.E.); Mayo Clinic, Scottsdale (D.W.N.), and University of Arizona, Tucson (J.E.L., R.K.V.) - both in Arizona; University of Kansas, Lawrence (Q.J.K.); and Emory University, Atlanta (W.C.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1513750DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259558PMC
July 2016

Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.

N Engl J Med 2016 Jul;375(1):23-34

From University of California, San Francisco (UCSF) (H.S.R., C.Y., L.J.V., M.B.B., N.M.H., A.J.C., C.E., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California San Diego, San Diego (A.M.W., R.S.), and University of Southern California, Los Angeles (D.T.) - all in California; University of Chicago (O.I.O., R.N.), and Loyola University (K.S.A.), Chicago; University of Pennsylvania, Philadelphia (A.D.); Gemini Group, Ann Arbor, MI (J.P.); University of Texas M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), UT Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas; University of Minnesota, Minneapolis (D.Y.), and Mayo Clinic, Rochester (J.C.B., T.C.H.) - both in Minnesota; Swedish Medical Center, Seattle (H.G.K.); Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.); University of Kansas, Lawrence (Q.J.K.); University of Arizona, Tucson (J.E.L., R.K.V.), and Mayo Clinic, Scottsdale (D.W.N.) - both in Arizona; Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.); University of Denver, Denver (A.D.E.); Inova Fairfax Hospital, Falls Church, VA (K.K.E.); and Emory University, Atlanta (W.C.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1513749DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259561PMC
July 2016

Early and Severe Radiation Esophagitis Associated With Concurrent Sirolimus.

J Clin Oncol 2016 Mar 14;34(9):e73-5. Epub 2014 Jul 14.

Pritzker School of Medicine, University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.50.1643DOI Listing
March 2016

Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003).

J Clin Oncol 2015 Aug 13;33(24):2623-31. Epub 2015 Jul 13.

Nancy U. Lin, Hao Guo, Nicole Ryabin, Julie S. Najita, William T. Barry, Ian E. Krop, Eric P. Winer, and Annick D. Van den Abbeele, Dana-Farber Cancer Institute; Andrea L. Richardson and Annick D. Van den Abbeele, Brigham and Women's Hospital, Boston, MA; Jeffrey T. Yap, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Ingrid A. Mayer and Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN; Carla I. Falkson, University of Alabama, Birmingham, AL; Timothy J. Hobday, Mayo Clinic, Rochester, MN; E. Claire Dees, University of North Carolina, Chapel Hill, NC; Rita Nanda, University of Chicago, Chicago, IL; Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; and Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.0353DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534525PMC
August 2015

Treatment of leptomeningeal carcinomatosis: current challenges and future opportunities.

J Clin Neurosci 2015 Apr 9;22(4):632-7. Epub 2015 Feb 9.

University of Chicago, Department of Neurology, 5841 S. Maryland Avenue, MC 2030, Chicago, IL 60637, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2014.10.022DOI Listing
April 2015

Gene expression of peripheral blood cells reveals pathways downstream of glucocorticoid receptor antagonism and nab-paclitaxel treatment.

Pharmacogenet Genomics 2014 Sep;24(9):451-8

aCommittee on Clinical Pharmacology and Pharmacogenetics Departments of bMedicine cHuman Genetics, The University of Chicago, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122588PMC
September 2014

The role of tumor-associated macrophages in breast cancer progression (review).

Int J Oncol 2013 Jul 14;43(1):5-12. Epub 2013 May 14.

Section of Hematology Medical and Oncology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2013.1938DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742164PMC
July 2013

A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer.

Breast Cancer Res Treat 2013 May 19;139(1):145-53. Epub 2013 Apr 19.

Section of Breast Oncology, Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, 660 South Euclid Avenue, P.O. Box 8056, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2528-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517667PMC
May 2013

"Targeting" triple-negative breast cancer: the lessons learned from BRCA1-associated breast cancers.

Authors:
Rita Nanda

Semin Oncol 2011 Apr;38(2):254-62

Department of Medicine, The University of Chicago, Chicago, IL 60637-1470, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009377541100017
Publisher Site
http://dx.doi.org/10.1053/j.seminoncol.2011.01.007DOI Listing
April 2011

Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer.

J Clin Oncol 2009 Sep 24;27(27):4515-21. Epub 2009 Aug 24.

Center for Clinical Cancer Genetics and Global Health, Department of Medicine, Section of Hematology/Oncology, University of Chicago, 5841 S Maryland Ave, MC 2115, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.19.6873DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754904PMC
September 2009

Advances in breast cancer: pathways to personalized medicine.

Clin Cancer Res 2008 Dec;14(24):7988-99

Department of Medicine, Section of Hematology/Oncology, Center for Clinical Cancer Genetics, University of Chicago, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/clincanres/14/
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-08-1211DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535810PMC
December 2008

Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers.

Breast Cancer Res Treat 2008 Sep 12;111(1):113-20. Epub 2007 Oct 12.

Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL 60637-1463, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-007-9766-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535794PMC
September 2008

Targeting the human epidermal growth factor receptor 2 (HER2) in the treatment of breast cancer: recent advances and future directions.

Authors:
Rita Nanda

Rev Recent Clin Trials 2007 May;2(2):111-6

Section of Hematology/Oncology, Department of Medicine, University of Chicago, USA.

View Article

Download full-text PDF

Source
May 2007

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

Mod Pathol 2006 Feb;19(2):264-71

Department of Pathology and Lab Medicine, University of North Carolina, Chapel Hill, NC 27599-7525, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.3800528DOI Listing
February 2006

BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.

Cancer Res 2005 Dec;65(23):10692-9

Center for Clinical Cancer Genetics, Department of Medicine, University of Chicago, Chicago, Illinois 60637-1463, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-1277DOI Listing
December 2005

Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.

JAMA 2005 Oct;294(15):1925-33

Center for Clinical Cancer Genetics, Section of Hematology/Oncology, Department of Medicine, University of Chicago Medical Center, Chicago, Ill 60637-1470, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.294.15.1925DOI Listing
October 2005